| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Caissa Capital Management Ltd. is a 10% Owner at Avalo Therapeutics, Inc.. Recent SEC Form 4 filings include 25 buys and 0 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 1,608,000 | $0.64 | $1,030,178.81 | -100% | -67.4% | -88.4% | |
| Jun 20, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 8,160 | $3.88 | $31,643.69 | +0.2% | -97.0% | -98.6% | |
| Jun 14, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 16,899 | $3.77 | $63,629.34 | +0.4% | -95.9% | -98.4% | |
| Jun 9, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 14,426 | $3.91 | $56,439.70 | +0.3% | -97.6% | -98.9% | |
| May 31, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 844 | $2.87 | $2,422.28 | - | -96.6% | -98.3% | |
| May 30, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 2,671 | $2.79 | $7,463.76 | - | -96.5% | -98.2% | |
| May 24, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 9,000 | $2.98 | $26,816.45 | +0.3% | -96.9% | -98.4% | |
| May 22, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 26,621 | $3.36 | $89,372.49 | +0.7% | -96.3% | -98.5% | |
| May 16, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 4,379 | $2.51 | $11,006.72 | +0.1% | -95.3% | -98.4% | |
| May 8, 2023 | AVTX Avalo Therapeutics, Inc. | 10% Owner | Buy | 25,000 | $2.77 | $69,364.50 | +0.6% | -93.9% | -97.9% |